A detailed history of Schneider Downs Wealth Management Advisors, LP transactions in Amgen Inc stock. As of the latest transaction made, Schneider Downs Wealth Management Advisors, LP holds 2,781 shares of AMGN stock, worth $878,796. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,781
Previous 2,790 0.32%
Holding current value
$878,796
Previous $793,000 9.46%
% of portfolio
0.2%
Previous 0.19%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $2,364 - $2,873
-9 Reduced 0.32%
2,781 $868,000
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $275,860 - $332,998
1,026 Added 58.16%
2,790 $793,000
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $13,119 - $16,287
60 Added 3.52%
1,764 $474,000
Q1 2023

May 04, 2023

SELL
$225.79 - $275.2 $12,418 - $15,136
-55 Reduced 3.13%
1,704 $411,000
Q4 2022

Feb 01, 2023

BUY
$229.03 - $291.01 $163,069 - $207,199
712 Added 68.0%
1,759 $461,000
Q3 2022

Oct 26, 2022

SELL
$224.46 - $253.15 $46,912 - $52,908
-209 Reduced 16.64%
1,047 $236,000
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $5,537 - $6,161
-24 Reduced 1.88%
1,256 $306,000
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $13,156 - $14,554
60 Added 4.92%
1,280 $310,000
Q4 2021

Jan 31, 2022

SELL
$198.88 - $227.6 $12,728 - $14,566
-64 Reduced 4.98%
1,220 $274,000
Q3 2021

Oct 14, 2021

BUY
$212.27 - $248.7 $4,882 - $5,720
23 Added 1.82%
1,284 $273,000
Q2 2021

Jul 20, 2021

BUY
$233.58 - $259.14 $3,036 - $3,368
13 Added 1.04%
1,261 $307,000
Q1 2021

Apr 26, 2021

BUY
$221.91 - $258.6 $276,943 - $322,732
1,248 New
1,248 $311,000
Q4 2020

Jan 21, 2021

SELL
$216.38 - $257.67 $283,890 - $338,063
-1,312 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$234.65 - $260.95 $2,581 - $2,870
11 Added 0.85%
1,312 $333,000
Q1 2020

Apr 21, 2020

BUY
$182.24 - $241.7 $237,094 - $314,451
1,301 New
1,301 $264,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Schneider Downs Wealth Management Advisors, LP Portfolio

Follow Schneider Downs Wealth Management Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schneider Downs Wealth Management Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Schneider Downs Wealth Management Advisors, LP with notifications on news.